grant

Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike

Organization DUKE UNIVERSITYLocation DURHAM, UNITED STATESPosted 1 Feb 2022Deadline 31 Jan 2027
NIHUS FederalResearch GrantFY20252019 novel corona virus2019 novel coronavirus2019-nCoV2019-nCoV S protein2019-nCoV spike glycoprotein2019-nCoV spike proteinAntibodiesAntigensB.1.1.7B.1.351B.1.617.2BiochemicalBiochemistryBiologicalBiological ChemistryBiophysicsCOVID-19COVID-19 S proteinCOVID-19 predispositionCOVID-19 spikeCOVID-19 spike glycoproteinCOVID-19 spike proteinCOVID-19 susceptibilityCOVID-19 virusCOVID-19 vulnerabilityCOVID19 virusCV-19CoV S proteinCoV glycoprotein SCoV spike glycoproteinCoV spike proteinCoV-2CoV2CommunicationComputing MethodologiesCoronaviridaeCoronavirusCoronavirus Infectious Disease 2019Coronavirus disease 2019 predispositionCoronavirus disease 2019 susceptibilityCoronavirus disease 2019 vulnerabilityCoronavirus glycoprotein SCoronavirus spike proteinCryo-electron MicroscopyCryoelectron MicroscopyDNA mutationDataData SetDelta variantEconomicsElectron CryomicroscopyElectron MicroscopyEmergenciesEmergency SituationEngineeringEpitheliasin GeneEsteroproteasesEvolutionFundingGenetic ChangeGenetic defectGenetic mutationGenetics-MutagenesisGoalsGrantImmune EvasionIn VitroKineticsLife CycleLife Cycle StagesLinkMeasuresMethodsMinkMolecularMolecular ConfigurationMolecular ConformationMolecular StereochemistryMutagenesisMutagenesis Molecular BiologyMutationNational Institutes of HealthNegative StainingOrthocoronavirinaePRSS10PathogenesisPeptidasesPeptide HydrolasesPeptidesPopulationPositionPositioning AttributePredisposed to COVID-19Predisposed to SARS-CoV-2Predisposed to Severe acute respiratory syndrome coronavirus 2PredispositionPropertyProtease GeneProteasesProtein CleavageProtein ConformationProteinasesProteinsProteolysisProteolytic EnzymesProtomerReceptor ProteinRecurrenceRecurrentReportingResearchResistanceResolutionRoleSARS corona virus 2SARS-CO-V2SARS-COVID-2SARS-CoV-2SARS-CoV-2 B.1.1.7SARS-CoV-2 B.1.351SARS-CoV-2 B.1.617.2SARS-CoV-2 SSARS-CoV-2 S proteinSARS-CoV-2 alphaSARS-CoV-2 betaSARS-CoV-2 deltaSARS-CoV-2 predispositionSARS-CoV-2 spikeSARS-CoV-2 spike glycoproteinSARS-CoV-2 spike proteinSARS-CoV-2 susceptibilitySARS-CoV-2 vulnerabilitySARS-CoV2SARS-associated corona virus 2SARS-associated coronavirus 2SARS-coronavirus-2SARS-related corona virus 2SARS-related coronavirus 2SARSCoV2Severe Acute Respiratory Coronavirus 2Severe Acute Respiratory Distress Syndrome CoV 2Severe Acute Respiratory Distress Syndrome Corona Virus 2Severe Acute Respiratory Distress Syndrome Coronavirus 2Severe Acute Respiratory Syndrome CoV 2Severe Acute Respiratory Syndrome-associated coronavirus 2Severe Acute Respiratory Syndrome-related coronavirus 2Severe acute respiratory syndrome associated corona virus 2Severe acute respiratory syndrome coronavirus 2Severe acute respiratory syndrome coronavirus 2 S proteinSevere acute respiratory syndrome coronavirus 2 predispositionSevere acute respiratory syndrome coronavirus 2 spike glycoproteinSevere acute respiratory syndrome coronavirus 2 spike proteinSevere acute respiratory syndrome coronavirus 2 susceptibilitySevere acute respiratory syndrome coronavirus 2 vulnerabilitySevere acute respiratory syndrome related corona virus 2Single Crystal DiffractionSiteSouth Africa strainSouth Africa variantSouth African strainSouth African variantStructureSurfaceSusceptibilityTMPRSS2TMPRSS2 geneTechniquesTechnologyU.K. variantUK strainUK variantUnited Kingdom variantUnited States National Institutes of HealthVaccine DesignVaccinesVariantVariationViralVirusWorkWuhan coronavirusX Ray CrystallographiesX-Ray CrystallographyX-Ray Diffraction CrystallographyX-Ray/Neutron CrystallographyXray Crystallographyadvanced simulationbeta CoVbeta coronavirusbetaCoVbetacoronavirusbiologicbiophysical analysisbiophysical foundationbiophysical principlesbiophysical sciencesbiophysical studiescombatcomputational methodologycomputational methodscomputational studiescomputer based methodcomputer methodscomputer studiescomputing methodconformationconformationalconformational stateconformationallyconformationscorona viruscoronavirus S proteincoronavirus disease 2019coronavirus disease 2019 S proteincoronavirus disease 2019 spike glycoproteincoronavirus disease 2019 spike proteincoronavirus disease 2019 viruscoronavirus disease-19coronavirus disease-19 viruscoronavirus infectious disease-19coronavirus spike glycoproteincryo-EMcryoEMcryogenic electron microscopycurrent pandemicdesigndesigningdevelop a vaccinedevelop vaccinesdevelopment of a vaccineeconomicexpectationexperimentexperimental researchexperimental studyexperimentsfuture pandemicgenome mutationglobal healthhCoV19hesitant to vaccinationimmune evasiveimmunogenin vivoinnovateinnovationinnovativeinsightlife coursenCoV2neutralizing antibodynew vaccinesnext generation vaccinesnext pandemicnovel vaccinespandemic containmentpandemic controlpandemic mitigationpandemic responsepredisposed to Coronavirus disease 2019present pandemicprotein structureprotein structuresproteins structurereceptorreceptor bindingreceptor boundreconstructionresistantresolutionssevere acute respiratory syndrome coronavirus 2 B.1.1.7severe acute respiratory syndrome coronavirus 2 B.1.351severe acute respiratory syndrome coronavirus 2 B.1.617.2social rolespike proteins on SARS-CoV-2structural biologysusceptible to COVID-19susceptible to Coronavirus disease 2019susceptible to SARS-CoV-2susceptible to Severe acute respiratory syndrome coronavirus 2synergismvaccination hesitancyvaccine developmentvaccine hesitancyvaccine hesitantvariants of concernvulnerable to COVID-19vulnerable to Coronavirus disease 2019vulnerable to SARS-CoV-2vulnerable to Severe acute respiratory syndrome coronavirus 2β CoVβ coronavirusβCoV
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike
COVID-19, caused by SARS-CoV-2, has devasted global health and economics. Vaccines are being

deployed worldwide to gain control of the pandemic, although emergence of fast-spreading “variants of

concern” (VOCs) have caused concern. Mutations in the spike (S) protein are under scrutiny due to its

essential role in the virus life cycle, and being the dominant target of neutralizing antibodies. Widespread

vaccine hesitancy and the current spread of the Delta variant provide fertile ground for emergence of vaccine-

resistant variants. We and others have shown that variants use a plethora of strategies to modify antibody and

receptor interactive surfaces, and spike conformation, resulting in antibody evasion and greater infectivity.

Over the last two years, utilizing urgent supplement funding from the NIH, we studied the structures of SARS-

CoV-2 S proteins and have established workflows spanning structure, biochemistry, biophysics and

computation. Here we propose to continue the essential work of detangling the effects of variant S protein

mutations, and to enhance our understanding of spike structure to further efforts to predict where the virus is

heading and to inform novel vaccine designs. The scientific premise of this grant is that understanding spike

structure and allostery will provide insights into its function, inform vaccine development, and provide

mechanistic information essential for relating spike structure to beta-CoV replication, evolution, and immune

evasion. The innovations in this grant derive from technologies we have developed for structural analyses of

the S protein: an integrative structural biology pipeline combines cryo-electron microscopy (cryo-EM), Negative

Stain Electron Microscopy (NSEM) and X-ray crystallography, with computational methods, and biochemical

and biophysical analyses to study structural and functional properties of the spike, including furin cleavage,

receptor binding, and antigenicity.

Grant Number: 5R01AI165947-04
NIH Institute/Center: NIH

Principal Investigator: Priyamvada Acharya

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →